Omeprazole, a proton pump inhibitor, suppresses gastric acid secretion
thereby producing gastrin hypersecretion. Using omeprazole we studied
the regulation of antral somatostatin. Five subjects ingested 20 mg o
f omeprazole each and seven others took 40 mg each, all for a period o
f eight days. Both types of treatment significantly increased basal se
rum gastrin levels, but we observed no significant difference between
the results effected by the two dosages. Subjects who ingested 40 mg/d
ay of omeprazole experienced a significant decrease of antral somatost
atin content, while the five who took only 20 mg/day did not. Antral s
omatostatin mRNA levels were found unchanged following both forms of t
reatment. These results indicate that antral somatostatin might be one
of the factors that cause gastrin hypersecretion by administration of
omeprazole.